Clinical Trials Directory

Trials / Completed

CompletedNCT02137278

Stop Vasodepressor Drugs in Reflex Syncope

Randomized Controlled Trial on Discontinuation of Vasoactive Drugs in Patients With Hypotensive Reflex Syncope

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Gruppo Italiano Multidisciplinare per lo Studio della Sincope · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Investigate clinical effects (reduction of number of syncope and associate symptoms) of suspension of vasoactive drugs in patients affected by vasodepressor reflex syncope.

Detailed description

Several drugs which are commonly used in clinical practice, such as antihypertensive, antiarrhythmic and psychiatric drugs, are associated with orthostatic hypotension and syncope. This phenomenon is much more evident in the elderly and with multiple therapies. The present study was aimed to investigate, in patients affected by reflex syncope, the clinical effects (reduction in syncope recurrence and associated symptoms) and the laboratory tests (negativization of carotid sinus massage and tilt table test) when such drugs are discontinued or reduced

Conditions

Interventions

TypeNameDescription
DRUGVasoactive drug therapiesContinue current vasoactive therapy
OTHERStop/reduce vasoactive drugsDiscontinuation of any vasoactive therapy or reduction of vasoactive drug therapies as much as possible according to clinical judgment.

Timeline

Start date
2014-03-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-05-13
Last updated
2015-12-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02137278. Inclusion in this directory is not an endorsement.